ASLAN Pharmaceuticals announced a collaboration with renowned inflammatory skin disease expert Dr. Emma Guttman-Yassky to conduct research that will continue throughout ASLAN’s Phase IIb program to identify and characterize the effects of ASLAN004 on disease-associated skin and serum-biomarkers in adults with moderate-to-severe atopic dermatitis.
[ASLAN Pharmaceuticals]
Sorry, but the selected Zotpress account can't be found.
